+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Intelligence in Drug Discovery Market - Global Forecast 2026-2032- Product Image
Artificial Intelligence in Drug Discovery Market - Global Forecast 2026-2032- Product Image
New

Artificial Intelligence in Drug Discovery Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4995111
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Artificial intelligence in drug discovery is reshaping how organizations accelerate research, strengthen decision-making, and streamline collaboration across disciplines. Executives are steering transformations as AI moves from experimental use to a core component of modern discovery workflows.

Market Snapshot: Artificial Intelligence in Drug Discovery Market

The artificial intelligence in drug discovery market is experiencing robust expansion, climbing from USD 1.55 billion in 2025 to an expected USD 1.81 billion in 2026, with projections pointing to USD 4.93 billion by 2032. This growth is primarily driven by sustained adoption of AI to fast-track target identification, enhance lead optimization, and mitigate clinical risks. The market’s compound annual growth rate reflects increasing demand among pharmaceutical and biotechnology organizations seeking competitive advantage and operational efficiency.

Scope & Segmentation

  • Application Areas: • ADMET and Toxicology Prediction, emphasizing Pharmacodynamics, Pharmacokinetics, and Toxicity • Clinical Trial Optimization, including Patient Recruitment and Trial Design • Hit Identification, utilizing High-Throughput Screening and In Silico Target Validation • Lead Optimization, applying De Novo Drug Design and Quantitative Structure-Activity Relationship Modeling • Protein Structure Prediction through Ab Initio, Homology Modeling, and Molecular Dynamics
  • Technology Types: • Computer Vision for phenotypic screening • Deep Learning for pattern recognition in large datasets • Machine Learning for predictive modeling and feature selection • Natural Language Processing to extract insights from scientific literature and clinical data
  • End Users: • Academic and research institutes prioritizing reproducibility and open science • Biotechnology companies focused on rapid discovery and IP creation • Contract research organizations offering scalable, standardized services • Pharmaceutical companies balancing regulatory readiness and integrated operations
  • Deployment Modes: • Cloud-based • Hybrid • On-premises, selected according to data residency needs and workflow integration
  • Regional Coverage: • Americas with established innovation and proactive regulatory engagement • Europe, Middle East & Africa emphasizing data protection and federated learning • Asia-Pacific leveraging government investment, local expertise, and agile market entry

Artificial Intelligence in Drug Discovery Market: Key Takeaways

  • AI integration is increasingly central to R&D strategies, supporting hypothesis testing and informed decision-making across target identification, lead optimization, and pipeline de-risking.
  • Organizations are reconfiguring processes, redeploying talent, and investing in curated datasets, ensuring the transition from proof-of-concept to reproducible, scalable discovery workflows.
  • Cross-functional teams and partnerships with technology providers and contract organizations are minimizing handoff friction and expanding collaborative ecosystems.
  • Cloud-native architectures and hybrid compute models offer flexibility for scaling computational workloads and ensuring compliance with regional data and governance requirements.
  • Segmentation analysis underscores the importance of tailoring AI investments to application-specific needs, user archetypes, and deployment preferences to optimize ROI.

Tariff Impact on the AI-Driven Drug Discovery Value Chain

United States tariff impositions in 2025 are influencing the economics of research hardware, software, and supply chains. Elevated costs for compute hardware and high-performance storage are driving organizations to re-evaluate investments between on-premises resources and cloud service usage. These changes necessitate revisiting procurement strategies, supporting the shift toward resilient, diversified vendor networks, and incentivizing adoption of in silico techniques that reduce reliance on traditional laboratory throughput. International collaborations now require robust governance to manage data exchanges, compliance, and unintended delays in cross-border partnerships.

Methodology & Data Sources

The analysis was developed using a rigorous multi-method approach. Structured interviews with computational scientists, translational biologists, clinical strategists, procurement leaders, and regulatory experts provided frontline insights. Secondary research included peer-reviewed publications, official guidance, vendor documentation, and corporate disclosures. Data triangulation and expert panel review validated findings, ensuring practical relevance and minimizing bias.

Why This Report Matters

  • Enables senior decision-makers to prioritize technology adoption and partnership models that align with operational risk tolerance and strategic objectives.
  • Deliver tailored guidance on segmentation-driven opportunities and regional nuances, supporting optimized investment and deployment strategies.
  • Provides actionable insights into supply chain resilience and governance frameworks for research continuity under evolving policy and market conditions.

Conclusion

Artificial intelligence is a foundational enabler for transformation across the drug discovery value chain. By aligning data, talent, governance, and infrastructure, organizations can sustain progress and competitive advantage while navigating dynamic regulatory and operational environments.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Artificial Intelligence in Drug Discovery Market, by Technology
8.1. Computer Vision
8.2. Deep Learning
8.3. Machine Learning
8.4. Natural Language Processing
9. Artificial Intelligence in Drug Discovery Market, by Therapeutic Area
9.1. Cardiovascular Diseases
9.2. Central Nervous System
9.3. Infectious Diseases
9.4. Oncology
10. Artificial Intelligence in Drug Discovery Market, by Application
10.1. ADMET & Toxicology Prediction
10.1.1. Pharmacodynamics Prediction
10.1.2. Pharmacokinetics Prediction
10.1.3. Toxicity Prediction
10.2. Clinical Trial Optimization
10.2.1. Patient Recruitment
10.2.2. Trial Design Optimization
10.3. Hit Identification
10.3.1. High Throughput Screening
10.3.2. In Silico Target Validation
10.3.3. Virtual Screening
10.4. Lead Optimization
10.4.1. De Novo Drug Design
10.4.2. Quantitative Structure Activity Relationship
10.4.3. Structure Based Drug Design
10.5. Protein Structure Prediction
10.5.1. Ab Initio Modeling
10.5.2. Homology Modeling
10.5.3. Molecular Dynamics Simulation
11. Artificial Intelligence in Drug Discovery Market, by End User
11.1. Academic & Research Institutes
11.2. Biotechnology Companies
11.3. Contract Research Organizations
11.4. Pharmaceutical Companies
12. Artificial Intelligence in Drug Discovery Market, by Deployment Mode
12.1. Cloud Based
12.2. Hybrid
12.3. On Premises
13. Artificial Intelligence in Drug Discovery Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Artificial Intelligence in Drug Discovery Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Artificial Intelligence in Drug Discovery Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Artificial Intelligence in Drug Discovery Market
17. China Artificial Intelligence in Drug Discovery Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AstraZeneca plc
18.6. Atomwise, Inc.
18.7. BenevolentAI Limited
18.8. Exscientia plc
18.9. Iktos SAS
18.10. Insilico Medicine
18.11. insitro, Inc.
18.12. Isomorphic Labs Limited
18.13. Novartis AG
18.14. Owkin, Inc.
18.15. Pfizer Inc.
18.16. Recursion Pharmaceuticals
18.17. Schrödinger, Inc.
18.18. Tempus Labs, Inc.
List of Figures
FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COMPUTER VISION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACODYNAMICS PREDICTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACODYNAMICS PREDICTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACODYNAMICS PREDICTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACOKINETICS PREDICTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACOKINETICS PREDICTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACOKINETICS PREDICTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TOXICITY PREDICTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TOXICITY PREDICTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TOXICITY PREDICTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PATIENT RECRUITMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PATIENT RECRUITMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PATIENT RECRUITMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TRIAL DESIGN OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TRIAL DESIGN OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TRIAL DESIGN OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY IN SILICO TARGET VALIDATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY IN SILICO TARGET VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY IN SILICO TARGET VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY VIRTUAL SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY VIRTUAL SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY VIRTUAL SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DE NOVO DRUG DESIGN, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DE NOVO DRUG DESIGN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DE NOVO DRUG DESIGN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY STRUCTURE BASED DRUG DESIGN, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY STRUCTURE BASED DRUG DESIGN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY STRUCTURE BASED DRUG DESIGN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY AB INITIO MODELING, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY AB INITIO MODELING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY AB INITIO MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HOMOLOGY MODELING, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HOMOLOGY MODELING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HOMOLOGY MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY MOLECULAR DYNAMICS SIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY MOLECULAR DYNAMICS SIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY MOLECULAR DYNAMICS SIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLOUD BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLOUD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ON PREMISES, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ON PREMISES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ON PREMISES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 159. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 161. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 162. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 164. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 165. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 166. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 167. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 168. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. EUROPE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 181. AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 183. AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 184. AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 186. AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 187. AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 188. AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 189. AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 190. AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. AFRICA ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. ASEAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. ASEAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 206. ASEAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 207. ASEAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. ASEAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 209. ASEAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 210. ASEAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 211. ASEAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 212. ASEAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 213. ASEAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. ASEAN ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 215. GCC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. GCC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 217. GCC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 218. GCC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. GCC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 220. GCC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 221. GCC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 222. GCC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 223. GCC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 224. GCC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. GCC ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 237. BRICS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. BRICS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 239. BRICS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 240. BRICS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 241. BRICS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 242. BRICS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 243. BRICS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 244. BRICS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 245. BRICS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 246. BRICS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. BRICS ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 248. G7 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 249. G7 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 250. G7 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 251. G7 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. G7 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY ADMET & TOXICOLOGY PREDICTION, 2018-2032 (USD MILLION)
TABLE 253. G7 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIAL OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 254. G7 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY HIT IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 255. G7 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 256. G7 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, 2018-2032 (USD MILLION)
TABLE 257. G7 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. G7 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 259. NATO ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 201

Companies Mentioned

The key companies profiled in this Artificial Intelligence in Drug Discovery market report include:
  • AstraZeneca plc
  • Atomwise, Inc.
  • BenevolentAI Limited
  • Exscientia plc
  • Iktos SAS
  • Insilico Medicine
  • insitro, Inc.
  • Isomorphic Labs Limited
  • Novartis AG
  • Owkin, Inc.
  • Pfizer Inc.
  • Recursion Pharmaceuticals
  • Schrödinger, Inc.
  • Tempus Labs, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.81 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.93 Billion
Compound Annual Growth Rate17.9%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Generative Artificial Intelligence (AI) in Drug Discovery Market Report 2025 - Product Image

Generative Artificial Intelligence (AI) in Drug Discovery Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Computer-aided Drug Discovery Market - Global Forecast 2025-2032 - Product Image

Computer-aided Drug Discovery Market - Global Forecast 2025-2032

  • Report
  • 186 Pages
  • Global
From
In-Silico Drug Discovery Market - Global Forecast 2025-2032 - Product Image

In-Silico Drug Discovery Market - Global Forecast 2025-2032

  • Report
  • 181 Pages
  • Global
From
Drug Discovery Services Market Report 2025 - Product Image

Drug Discovery Services Market Report 2025

  • Report
  • 200 Pages
  • Global
From
AI in Drug Discovery Market, till 2040: Distribution by Drug Discovery Steps, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global Forecasts - Product Image

AI in Drug Discovery Market, till 2040: Distribution by Drug Discovery Steps, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global Forecasts

  • Report
  • 387 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.